Phosphatidylserine Data Limited To Dementia Mitigation Not Prevention – FDA
This article was originally published in The Tan Sheet
Executive Summary
All the data submitted to FDA in support of a health claim linking phosphatidylserine to prevention of dementia or cognitive dysfunction examine the ingredient's ability to mitigate the conditions in a diseased population, not on reducing risk in the general population, the agency said in a May 13 letter
You may also be interested in...
Brain Gain: Supplements And Nutraceuticals Expand Cognitive Health Science
The next generation of substances to slow cognitive decline and perhaps even prevent Alzheimer's disease may take a test run through the dietary supplement and nutraceutical markets
Brain Gain: Supplements And Nutraceuticals Expand Cognitive Health Science
The next generation of substances to slow cognitive decline and perhaps even prevent Alzheimer's disease may take a test run through the dietary supplement and nutraceutical markets
Brain Gain: Supplements And Nutraceuticals Expand Cognitive Health Science
The next generation of substances to slow cognitive decline and perhaps even prevent Alzheimer's disease may take a test run through the dietary supplement and nutraceutical markets